CD44 and breast carcinoma: All these in vitro studies for phenotypical and functional properties of CSCs were notably increased in the TS subpopulations for all cell lines, except for CD44+/CD24− expression in MDA-MB-231 breast cancer cells that is basally high in TP cells.